Drug class
Progestins
Progestins are synthetic progestogens engineered to replicate the biological activity of endogenous progesterone. Read more about Progestins
457 drugs in this class 84 manufacturers
Drugs in Progestins
NYLIA (norethindrone-ethinyl estradiol)
PLAN B ONE-STEP (levonorgestrel)
PREMPRO (estrogens, conjugated/medroxyprogesterone acetate)
PROGESTERONE (progesterone, micronized)
VIENVA (levonorgestrel/ethinyl estradiol)
VIORELE (desogestrel-ethinyl estradiol/ethinyl estradiol)
AZURETTE (desogestrel-ethinyl estradiol/ethinyl estradiol)
CAMILA (norethindrone)
Progestins are synthetic progestogens engineered to replicate the biological activity of endogenous progesterone.
They function by binding to intracellular progesterone receptors, thereby suppressing gonadotropin release, suppressing ovulation, thickening cervical mucus, and inhibiting estrogen-driven endometrial proliferation.
Clinically, progestins are widely utilized for contraception, the management of abnormal uterine bleeding, endometriosis, and secondary amenorrhea, as well as to prevent endometrial hyperplasia and malignancy in individuals with an intact uterus undergoing menopausal estrogen therapy.
Select agents are also indicated in oncology, including the palliative treatment of advanced hormone-dependent endometrial or breast cancers.
-
drugs.com
Progestins are synthetic progestogens engineered to replicate the biological activity of endogenous progesterone
-
nih.gov
Progestins are synthetic progestogens engineered to replicate the biological activity of endogenous progesterone
-
drugbank.com
They function by binding to intracellular progesterone receptors, thereby suppressing gonadotropin release, suppressing ovulation, thickening cervical mucus, and inhibiting estrogen-driven endometrial proliferation Select agents are also indicated in oncology, including the palliative treatment of advanced hormone-dependent endometrial or breast cancers
-
nih.gov
They function by binding to intracellular progesterone receptors, thereby suppressing gonadotropin release, suppressing ovulation, thickening cervical mucus, and inhibiting estrogen-driven endometrial proliferation
-
cancer.gov
They function by binding to intracellular progesterone receptors, thereby suppressing gonadotropin release, suppressing ovulation, thickening cervical mucus, and inhibiting estrogen-driven endometrial proliferation
-
fda.gov
Clinically, progestins are widely utilized for contraception, the management of abnormal uterine bleeding, endometriosis, and secondary amenorrhea, as well as to prevent endometrial hyperplasia and malignancy in individuals with an intact uterus undergoing menopausal estrogen therapy
-
fda.gov
Clinically, progestins are widely utilized for contraception, the management of abnormal uterine bleeding, endometriosis, and secondary amenorrhea, as well as to prevent endometrial hyperplasia and malignancy in individuals with an intact uterus undergoing menopausal estrogen therapy
-
nih.gov
Clinically, progestins are widely utilized for contraception, the management of abnormal uterine bleeding, endometriosis, and secondary amenorrhea, as well as to prevent endometrial hyperplasia and malignancy in individuals with an intact uterus undergoing menopausal estrogen therapy
-
clevelandclinic.org
Select agents are also indicated in oncology, including the palliative treatment of advanced hormone-dependent endometrial or breast cancers
-
nih.gov
Select agents are also indicated in oncology, including the palliative treatment of advanced hormone-dependent endometrial or breast cancers
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.